$5.19
7.35% today
Nasdaq, Jul 02, 05:37 pm CET
ISIN
US00973W1027
Symbol
PLUR

Akerna Corp Stock price

$4.83
+0.36 8.05% 1M
+0.56 12.98% 6M
+0.56 12.98% YTD
-0.93 16.07% 1Y
-5.25 52.08% 3Y
-65.09 93.09% 5Y
-195.97 97.59% 10Y
+4.61 2,095.45% 20Y
Nasdaq, Closing price Tue, Jul 01 2025
-0.12 2.42%
ISIN
US00973W1027
Symbol
PLUR

Key metrics

Basic
Market capitalization
$37.8m
Enterprise Value
$36.5m
Net debt
positive
Cash
$26.3m
Shares outstanding
7.8m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
36.73 | 20.27
EV/Sales
35.44 | 19.56
EV/FCF
negative
P/B
negative
Financial Health
Equity Ratio
0.24%
Return on Equity
-21,758.33%
ROCE
-68.10%
ROIC
-
Debt/Equity
-5.58
Financials (TTM | estimate)
Revenue
$1.0m | $1.9m
EBITDA
$-21.3m | -
EBIT
$-21.6m
Net Income
$-20.7m | $-24.4m
Free Cash Flow
$-18.2m
Growth (TTM | estimate)
Revenue
202.94% | 465.45%
EBITDA
4.82% | -
EBIT
4.76%
Net Income
4.87% | -16.80%
Free Cash Flow
-7.05%
Margin (TTM | estimate)
Gross
52.13%
EBITDA
-2,062.19% | -
EBIT
-2,087.91%
Net
-2,003.29% | -1,307.72%
Free Cash Flow
-1,761.61%
More
EPS
$-3.15
FCF per Share
$-2.34
Short interest
0.62%
Employees
112.00
Rev per Employee
$0.00
Show more

Is Akerna Corp a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,970 stocks worldwide.

Akerna Corp Stock Analysis

Unlock Scores for Free

Analyst Opinions

7 Analysts have issued a Akerna Corp forecast:

6x Buy
86%
1x Hold
14%

Analyst Opinions

7 Analysts have issued a Akerna Corp forecast:

Buy
86%
Hold
14%

Financial data from Akerna Corp

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
1.03 1.03
203% 203%
100%
- Direct Costs 0.50 0.50
-
49%
0.54 0.54
-
52%
- Selling and Administrative Expenses 9.88 9.88
5% 5%
959%
- Research and Development Expense 14 14
84% 84%
1,312%
-21 -21
5% 5%
-2,070%
- Depreciation and Amortization 0.27 0.27
0% 0%
26%
EBIT (Operating Income) EBIT -22 -22
5% 5%
-2,096%
Net Profit -21 -21
5% 5%
-2,011%

In millions USD.

Don't miss a Thing! We will send you all news about Akerna Corp directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Akerna Corp Stock News

Neutral
PRNewsWire
about one month ago
NEW YORK , May 27, 2025 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapies for neurodegenerative diseases, today announced that it has signed a Letter of Intent (LOI) with Minaris Advanced Therapies, a global contract development and manufacturing organization (CDMO) specializing in cell and gene therapies, to manufacture NurOwn® f...
Neutral
GlobeNewsWire
2 months ago
Acquisition of approximately 71% stake in Kokomodo Ltd. Acquisition uniquely combines Pluri's mass-scale cell production expertise with Kokomodo Ltd.
Neutral
GlobeNewsWire
4 months ago
Strategic initiative to address Ukraine's urgent need for radiation countermeasures Hemafund's infrastructure ensures secure storage and rapid deployment of emergency treatments Collaboration may potentially generate over $100 million in value for both parties HAIFA, Israel, March 05, 2025 (GLOBE NEWSWIRE) -- Pluri Inc. (Nasdaq: PLUR) (TASE: PLUR) (“Pluri” or the “Company”), a leading biotechno...

Company Profile

Akerna Corp. is cannabis compliance, inventory tracking technology company. It engages in the provision of enterprise resource planning technology. Its products enable cannabis businesses and government agencies to manage the cannabis supply chain from seed-to-sale and collect and synthesize valuable data. The company was founded IN 2010, and is headquartered in Denver, CO.

Head office United States
CEO Yaky Yanay
Employees 112
Founded 2001
Website pluri-biotech.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today